Declarative memory abilities change across adulthood. Semantic memory and autobiographic episodic knowledge can remain stable or even increase from mid- to late adulthood, while episodic memory abilities decline in later adulthood. Although it is well known that prior knowledge influences new learning, it is unclear whether the experiential growth of knowledge and memory traces across the lifespan may drive favorable adaptations in some basic memory processes. We hypothesized that an increased reliance on memory integration may be an adaptive mechanism to handle increased interference from accumulating memory traces and knowledge across adulthood. In turn, this may confer an improved ability for integration, observable in middle-age, before the onset of major aging-related declines. We further tested whether the hypothesized increase would be associated with previously observed reductions in memory discrimination performance in midlife. Data from a sample of healthy middle-aged (40-50 years, = 40) and younger adults (20-28 years, = 41) did not support the hypothesis of improved integration, as assessed by an associative inference paradigm. Instead, age-equivalent performance on both integration and discrimination measures were observed [Bayes factors (BFs) = 0.19-0.25], along with expected higher verbal knowledge and slower perceptual speed for middle-aged [(BFs) = 8.52-73.52]. The results contribute to an increased understanding of memory processing in midlife, an understudied portion of the lifespan, and suggest that two core episodic memory processes, integration and discrimination, can be maintained in healthy middle-aged adults.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819667PMC
http://dx.doi.org/10.3389/fpsyg.2021.797387DOI Listing

Publication Analysis

Top Keywords

healthy middle-aged
12
memory
11
middle-aged adults
8
memory abilities
8
episodic memory
8
memory traces
8
memory processes
8
integration discrimination
8
integration
6
knowledge
5

Similar Publications

Factors behind poor cognitive outcome following a thalamic stroke.

J Neurol

January 2025

Brain and Cognition Research Center, (CerCo-UMR 5549), CNRS, University of Toulouse, Toulouse, France.

Background: Thalamic strokes produce neurological, cognitive, and behavioral symptoms depending on the thalamic nuclei involved. While traditionally associated with severe cognitive deficits, recent studies suggest more modest impairments. This study aims to identify the factors that influence the severity of cognitive impairment following thalamic stroke.

View Article and Find Full Text PDF

Background: With the approval of disease-modifying treatments for 5q-spinal muscular atrophy (SMA), there is an increasing need for biomarkers for disease course and therapeutic response monitoring. Radially sampled Averaged Magnetization Inversion Recovery Acquisitions (rAMIRA) MR-imaging enables spinal cord (SC) gray matter (GM) delineation and quantification in vivo. This study aims to assess SC GM atrophy in patients with 5q-SMA and its associations with clinical disability.

View Article and Find Full Text PDF

Self-replicating RNA (srRNA) technology, in comparison to mRNA vaccines, has shown dose-sparing by approximately 10-fold and more durable immune responses. However, no improvements are observed in the adverse events profile. Here, we develop an srRNA vaccine platform with optimized non-coding regions and demonstrate immunogenicity and safety in preclinical and clinical development.

View Article and Find Full Text PDF

Activation of the kynurenine pathway identified in individuals with covert hepatic encephalopathy.

Hepatol Commun

December 2024

Macquarie Medicine School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.

Background: HE is a neuropsychiatric complication of liver disease characterized by systemic elevation in ammonia and proinflammatory cytokines. These neurotoxins cross the blood-brain barrier and cause neuroinflammation, which can activate the kynurenine pathway (KP). This results in dysregulated production of neuroactive KP metabolites, such as quinolinic acid, which is known to cause astrocyte and neuronal death.

View Article and Find Full Text PDF

Background: There had been extensive research on the role of the gut microbiota in human health and disease. Increasing evidence suggested that the gut-brain axis played a crucial role in Parkinson's disease, with changes in the gut microbiota speculated to be involved in the pathogenesis of Parkinson's disease or interfere with its treatment. However, studies utilizing deep learning methods to predict Parkinson's disease through the gut microbiota were still limited.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!